These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36415961)

  • 21. Thiamazole Pretreatment Lowers the (131)I Activity Needed to Cure Hyperthyroidism in Patients With Nodular Goiter.
    Kyrilli A; Tang BN; Huyge V; Blocklet D; Goldman S; Corvilain B; Moreno-Reyes R
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2261-7. PubMed ID: 25867812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study.
    Mazza E; Carlini M; Flecchia D; Blatto A; Zuccarini O; Gamba S; Beninati S; Messina M
    J Endocrinol Invest; 2008 Oct; 31(10):866-72. PubMed ID: 19092290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
    Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
    Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid adenoma after radioactive iodine therapy for multinodular goiter.
    Cundiff JG; Portugal L; Sarne DH
    Am J Otolaryngol; 2001; 22(5):374-5. PubMed ID: 11562893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves' Hyperthyroid Patients: A Randomized Prospective Controlled Study.
    Lertwattanarak R; Kunavisarut T; Sriussadaporn S
    Int J Endocrinol; 2022; 2022():1705740. PubMed ID: 36267362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-Analysis of Randomized Controlled Trials Comparing the Efficacy of Radioactive Iodine Monotherapy versus Radioactive Iodine Therapy and Adjunctive Lithium for the Treatment of Hyperthyroidism.
    Ahmed FW; Kirresh OZ; Majeed MS; Iftikhar M; Sajid MS
    Endocr Res; 2021 Nov; 46(4):160-169. PubMed ID: 34028325
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of propylthiouracil on the efficacy of radioiodine (I-131) therapy in graves hyperthyroidism].
    de Souza MV; Buescu A; Vaisman M; de Souza HF; Luiz RR
    Arq Bras Endocrinol Metabol; 2006 Dec; 50(6):1088-95. PubMed ID: 17221116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
    Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
    [No Abstract]   [Full Text] [Related]  

  • 30. Subtle changes in serum thyrotrophin (TSH) and sex-hormone-binding globulin (SHBG) levels during long-term follow-up after radioactive iodine in multinodular non-toxic goitre.
    Jarløv AE; Faber J; Hegedüs L; Hansen JM
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):335-7. PubMed ID: 1483288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
    Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Risk of Radioiodine Treatment Failure Associated with Graves Disease Refractory to Methimazole.
    Kwak JJ; Altoos R; Jensen A; Altoos B; McDermott MT
    Endocr Pract; 2020 Nov; 26(11):1312-1319. PubMed ID: 33471662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
    Villagelin D; Romaldini JH; Santos RB; Milkos AB; Ward LS
    Thyroid; 2015 Dec; 25(12):1282-90. PubMed ID: 26414885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of long term thyrostatic treatment in elderly patients with toxic nodular goitre compared to radioiodine therapy with different doses.
    Takáts KI; Szabolcs I; Földes J; Földes I; Ferencz A; Rimanóczy E; Góth M; Dohán O; Kovács L; Szilágyi G
    Exp Clin Endocrinol Diabetes; 1999; 107(1):70-4. PubMed ID: 10077359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
    Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
    Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Radioiodine Therapy in Patients With Primary Hyperthyroidism: An Institutional Review From Pakistan.
    Alvi AM; Azmat U; Shafiq W; Ali Rasheed AH; Siddiqi AI; Khan S; Ashfaq S; Irfan H; Bashir H; Abu Bakar M; Asghar K
    Cureus; 2022 May; 14(5):e24992. PubMed ID: 35719786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic 131I dose in hyperthyroidism: role of pretreatment with thionamide.
    Kabadi U; Cech R
    Thyroidology; 1994 Dec; 6(3):87-92. PubMed ID: 7545000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL10 in hyperthyroid patients with Graves' disease.
    Leite AC; Pedro AB; Romaldini JH
    Horm Metab Res; 2011 Mar; 43(3):194-9. PubMed ID: 21283953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.